new tirzepatide Zepbound Now Available Through LillyDirect: A Option for Access at a Predictable Price New Blockbuster Type 2 Medication

Simon GE, Coleman KJ, Rossom RC, et al

2023;186:73247.e16

As of January 2021, only 14.2% of plans covered GLP-1s for obesity

Recently, the analyses of large datasets collecting routinely-accumulated data from clinical practice (ie, real-world studies, RWS) have provided new opportunities to complement the information obtained from RCTs

At Sunrise Healthcare Services, we integrate MAT into our core treatment strategy, using it to help patients manage cravings, withdrawal symptoms, and the psychological aspects of addiction

From the pharmacokinetics that explain why once-weekly dosing works, to the practical strategies for aligning injections with your schedule, meals, exercise routine, and sleep patterns